
Carl Regillo, MD, on missed wet AMD injections, treatment switching, and how gene therapy could ease chronic burden.
Carl Regillo, MD, FASRS, is the chief of retina service at Wills Eye Hospital and a professor of ophthalmology at Sidney Kimmel Medical College, Thomas Jefferson University.

Carl Regillo, MD, on missed wet AMD injections, treatment switching, and how gene therapy could ease chronic burden.

Carl Regillo, MD, explains why wet AMD anti‑VEGF results lag in real life and how newer agents extend dosing, yet the burden persists.